Logo

American Heart Association

  28
  0


Final ID:

Will apoCIII therapies tip the BALANCE towards targeting triglycerides?

  • Tsimikas, Sotirios  ( UNIV CALIFORNIA SAN DIEGO , La Jolla , California , United States )
  • Ballantyne, Christie  ( BAYLOR COLLEGE MEDICINE , Houston , Texas , United States )
  • Author Disclosures:
    Sotirios Tsimikas: DO have relevant financial relationships ; Royalties/Patent Beneficiary:UCSd:Active (exists now) ; Employee:Ionis:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Ownership Interest:Oxitope:Active (exists now) ; Ownership Interest:Kleanthi:Active (exists now) | Christie Ballantyne: DO have relevant financial relationships ; Researcher:merck:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Researcher:Novo Nordisk:Active (exists now) ; Consultant:Arrowhead:Active (exists now) ; Researcher:Arrowhead:Active (exists now) ; Consultant:Ionis:Active (exists now) ; Researcher:Ionis:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Researcher:Amgen:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Researcher:Eli Lilly:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Consultant:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Annual Lipid Update 2025

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available